Actavis, Inc. and the FDA agreed last week on a Consent Decree of Permanent Injunction, preventing the drug maker from distributing any products from their Actavis Totowa facility in New Jersey. This follows a series of manufacturing problems at the plant, including quality control problems which allowed oversized tablets of Digitek to be commercially released, resulting in hundreds of deaths and serious injuries. Continued
All Posts Tagged With: "Actavis"
Digitek Lawyers Appointed to Leadership Roles in Federal MDL
U.S. District Judge Joseph Goodwin, who is handling the consolidated Digitek lawsuits in West Virginia, has issued a pretrial order appointing Co-Lead Attorneys and members of the Plaintiffs’ Steering Committee in the MDL, or Multidistrict Litigation. These lawyers will perform services that benefit all of the plaintiffs during pretrial phase of the litigation. Continued
Congress Requests Information from FDA about Digitek Recall
The U.S. House Committee on Energy and Commerce has requested information from the FDA about a May 2008 Digitek recall issued by Actavis Totowa, as well as other regulatory issues involving the same generic drug maker in recent years. Continued
Actavis Recalls Over 65 Generic Drugs Made at NJ Plant
On August 1, 2008, Actavis Totowa, LLC announced the recall of over 65 different generic drugs the company manufactured at the same New Jersey plant where they previously produced defective Digitek tablets which were recalled in April 2008. The recall was extended to all medications made at the plant after an FDA investigation found that the drug maker was not following good manufacturing practices. Continued
